Clinical trial
Multicentre, Prospective, Randomized, Open-label, Assessor Blinded Study to Evaluate Granulox® Used as Adjunct Therapy to Defined Standard of Care vs. Defined Standard of Care for the Treatment of Predominantly Chronic Venous Leg Ulcers (VLUs)
NCT04181320 is registered in ClinicalTrials.gov with Molnlycke Health Care AB as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre, Prospective, Randomized, Open-label, Assessor Blinded Study to Evaluate Granulox® Used as Adjunct Therapy to Defined Standard of Care vs. Defined Standard of Care for the Treatment of Predominantly Chronic Venous Leg Ulcers (VLUs)
- Lead sponsor
- Molnlycke Health Care AB
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 8, 2020
- Completion date
- January 17, 2023
- Enrollment
- 128 (actual)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
venous leg ulcer